# Study Highlights Stroke Risk Linked to Recreational Drugs, Including Among Young Users > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-stroke-risk-young-users-study-highlights/ > **Published:** 2026-03-08T23:45:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:10:12-04:00 > **Clinical Summary:** New study highlights cannabis stroke risk young users face, emphasizing the importance of clinical awareness and patient education on recreational drug use. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchSafety[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) Why This Matters Clinicians need to recognize cannabis as a modifiable stroke risk factor, particularly when counseling younger patients presenting with acute neurological symptoms or those with multiple cardiovascular risk factors. This evidence should inform clinical assessment and [patient education](https://cedclinic.com/medical-cannabis-patient-education-basics/) about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), especially given the perception of safety among recreational users and the growing normalization of cannabis in many jurisdictions. Incorporating [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) history into standard stroke risk stratification may help identify high-risk individuals who could benefit from preventive interventions or lifestyle modification counseling. Clinical Summary A Cambridge University study examining stroke risk associated with recreational drug use found that cannabis, cocaine, and amphetamines all significantly increase stroke risk, with important implications for younger populations previously considered at lower cardiovascular risk. The research highlights that cannabis use is not risk-free from a cerebrovascular standpoint, challenging perceptions of cannabis as a benign substance among young adults and adolescents who may underestimate their stroke vulnerability. Clinicians should incorporate cannabis use history into cardiovascular risk assessments, particularly for younger patients, and counsel patients about stroke risk as part of informed consent discussions when cannabis use is being considered. The findings suggest that even [recreational cannabis use](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) carries acute vascular complications that warrant clinical attention and [patient education](https://cedclinic.com/medical-cannabis-patient-education-basics/). For clinicians managing young patients with stroke or those at risk for cerebrovascular events, detailed [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) screening including cannabis frequency and potency should be standard practice to identify modifiable risk factors. Dr. Caplan’s Take “What we’re seeing in the data is that cannabis, particularly when smoked and especially in younger patients with developing cerebrovascular systems, can acutely elevate blood pressure and heart rate in ways that precipitate stroke, and this risk is real enough that I counsel all my young patients about it during their cannabis conversations.” Clinical Perspective While cannabis has gained legal status in many jurisdictions and is increasingly perceived as low-risk, emerging evidence suggests that acute cannabis use may be associated with elevated stroke risk, particularly through mechanisms involving cerebral vasoconstriction and hypercoagulability. The clinical significance is heightened by the fact that younger users represent a substantial proportion of cannabis consumers, yet stroke is often underdiagnosed in this population due to lower clinical suspicion and atypical presentations. Important caveats include the difficulty isolating cannabis effects from concurrent use of other substances (cocaine, amphetamines), underlying cardiovascular risk factors, and the challenge of establishing causation from observational data. Given these complexities, clinicians should maintain awareness of cannabis use as a potential acute stroke risk factor and include it in [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) screening, particularly when evaluating young patients with acute neurological symptoms or transient ischemic attacks. A practical approach involves documenting cannabis use patterns in the 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Study+highlights+stroke+risk+linked+to+recreational+drugs%2C+including+among+young+users+%40drcaplan&url=https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1117771) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1117771) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Study+highlights+stroke+risk+linked+to+recreational+drugs%2C+including+among+young+users+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1117771) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026](https://cedclinic.com/daily-digest-last-9-hours-stroke-risk-from-recreational-drugs-and-dea-scheduling-actions-march-08-2026/) 📰 Source: [https://www.eurekalert.org/news-releases/1117771](https://www.eurekalert.org/news-releases/1117771) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Research Digest[Daily Digest 2026-03-07](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Marijuana Use Linked To Heart Attacks, Strokes In New Study – MSN](https://cedclinic.com/2026-cannabis-cardiovascular-risks-heart-attack-stroke-study/) Explore new research linking marijuana use to increased risks of heart attacks and strokes, highlighting important cardiovascular concerns. [Read More](https://cedclinic.com/2026-cannabis-cardiovascular-risks-heart-attack-stroke-study/) [Cannabis use predicts risks of heart failure and cerebrovascular accidents](https://cedclinic.com/cannabis-use-predicts-risks-of-heart-failure-and-cerebrovascular-accidents/) This article discusses how cannabis use can predict risks of heart failure and cerebrovascular events, emphasizing clinical relevance. [Learn More](https://cedclinic.com/cannabis-use-predicts-risks-of-heart-failure-and-cerebrovascular-accidents/) Teenage Cannabis Use Linked to 52% Higher Schizophrenia Risk – Neuroscience News Review findings on teenage cannabis use and its association with increased schizophrenia risk, underscoring [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) implications. Discover More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).